Stocktoria
MeiraGTx Holdings plc MGTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-08
MeiraGTx Holdings plc financials (annual, from 10-K)
| Metric | FY2025 | FY2025 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $81.4M | — | — | $33.3M | $14.0M |
| R&D expense | $129.6M | — | — | $119.5M | $103.8M |
| Operating income | -$106.0M | — | — | -$164.2M | -$137.1M |
| Interest expense | $12.2M | — | — | $13.3M | $13.2M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$114.2M | — | — | -$147.8M | -$84.0M |
| EPS (diluted) | $-1.42 | — | — | $-2.12 | $-1.49 |
| Operating cash flow | -$46.4M | — | — | -$104.5M | -$105.4M |
| Free cash flow | -$50.2M | — | — | -$109.5M | -$125.5M |
| Cash & equivalents | $65.9M | $14.8M | $32.2M | $103.7M | $129.6M |
| Inventory | — | — | $314,000 | $385,000 | — |
| Total assets | $244.4M | $189.5M | $198.7M | $269.8M | $326.7M |
| Total liabilities | $250.2M | $230.0M | $195.8M | $201.9M | $188.6M |
| Shareholders' equity | -$5.8M | -$40.6M | $3.0M | $67.8M | $138.2M |
Source: SEC EDGAR filings · CIK 0001735438 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.